IRWD
Ironwood Pharmaceuticals Inc
NASDAQ · Biotechnology
$4.56
+0.11 (+2.47%)
Open$4.52
Previous Close$4.45
Day High$4.71
Day Low$4.41
52W High$5.78
52W Low$0.53
Volume—
Avg Volume2.15M
Market Cap741.81M
P/E Ratio25.98
EPS$0.14
SectorBiotechnology
Analyst Ratings
Sell
9 analysts
Price Target
+1,033.8% upside
Current
$4.56
$4.56
Target
$51.70
$51.70
$40.79
$51.70 avg
$62.56
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 357.11M | 377.10M | 79.96M |
| Net Income | 894.7K | 850.3K | 13.20M |
| Profit Margin | 0.3% | 0.2% | 16.5% |
| EBITDA | 97.33M | 97.64M | 23.20M |
| Free Cash Flow | — | — | 16.46M |
| Rev Growth | -5.3% | -5.3% | +4.0% |
| Debt/Equity | 0.61 | 0.61 | 0.50 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |